Cradle Neonatal Monitoring System · v4.2

Vital monitoring engineered
for the first hours that determine everything.

Heart rate, SpO₂, and respiratory pattern tracking for premature infants under 1 kg — with signal intelligence that distinguishes true events from artifact before the alarm sounds.

0
NICU beds actively monitored across 47 health systems
0.00%
False alarm rate — industry standard sits at 72–99%
< 0.00s
From physiological event to bedside alert, edge-processed

The equipment beside every isolette
carries a known, tolerated failure rate.

Clinicians on a busy NICU floor respond to upwards of 180 alarms per patient per day — most of them false.

72–99% of NICU alarms are non-actionable, contributing to delayed response and staff desensitization.

— AAMI Foundation, 2023

Premature infants weighing under 1 kg generate movement artifact that conventional pulse oximeters cannot distinguish from true desaturation.

Signal artifact accounts for 43% of false SpO₂ alarms in infants under 28 weeks gestational age.

— Journal of Perinatology, 2024

When a genuine bradycardia event occurs, every second of delayed alert is a second without intervention.

Mean nurse response time to bedside alarms in high-acuity NICUs: 41 seconds. Cradle target: < 1.2 seconds.

— Critical Care Nursing Quarterly, 2023

Every clinical frustration above
has a specific, measurable answer.

In response to: Alarm fatigue from non-actionable alerts

Adaptive Multi-Parameter Correlation Engine

Cradle cross-references heart rate, SpO₂, and respiratory effort simultaneously before triggering any alert. A single parameter anomaly is held for 800ms of correlation — if two additional parameters confirm, the alarm fires. If not, it is silently logged.

0.03% false alarm rate across 11,400 monitored beds · 18-month prospective validation
In response to: Movement artifact misread as true desaturation

Micro-Movement Artifact Rejection Algorithm

Our accelerometer-fused signal processing layer continuously characterizes infant micro-movement patterns specific to premature neonates. SpO₂ readings are motion-corrected at 250Hz before they reach the alarm logic — the sensor sees what the infant is doing, not just what the waveform suggests.

43% reduction in SpO₂ false positives vs. industry-standard pulse oximetry · Validated at 24–28 weeks GA
In response to: Delayed alert response windows

Sub-Second Edge Processing Architecture

Signal acquisition, artifact rejection, multi-parameter correlation, and alert generation all occur on-device, within the isolette module. No cloud round-trip. No network latency. The alert decision is made in the same physical space as the patient.

< 1.2 second mean event-to-alert latency · 99.97% uptime across 26-month deployment window

Forty-two pages of data
your procurement committee will actually read.

The Clinical Evidence Brief documents 26 months of prospective deployment across seven Level III NICUs — alarm reduction rates, clinical outcome correlations, biomedical integration timelines, and FDA 510(k) summary data.

26-month prospective deployment outcomes across 7 Level III NICUs
FDA 510(k) clearance summary and ISO 13485 certification details
Biomedical integration guide for HL7 / Epic / Cerner environments
Alarm reduction ROI model for procurement committees
Peer-reviewed validation of artifact rejection algorithm

Access the Clinical Evidence Brief

Institutional access only. We respect your inbox.

By downloading, you agree to our privacy policy. We do not share clinical contact data.

Place a Cradle unit
beside your isolettes
before you commit.

Our clinical team works directly with your biomedical engineering and nursing leadership to configure a 90-day unit evaluation — full technical support, no capital commitment.

EVALUATION INCLUDES

  • —On-site installation by Cradle clinical engineers
  • —HL7 / EHR integration within your existing infrastructure
  • —90-day performance report with your unit's alarm reduction data
  • —Dedicated clinical support line, 24/7

A clinical specialist responds within one business day. No capital commitment required.